Jacobio Pharmaceuticals Group Co (HKSE:01167) GF Value : HK$1.78 (As of Jun. 05, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-06-05), Jacobio Pharmaceuticals Group Co's share price is HK$1.78. Jacobio Pharmaceuticals Group Co's GF Value is HK$1.78. Therefore, Jacobio Pharmaceuticals Group Co's Price-to-GF-Value for today is 1.00.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Jacobio Pharmaceuticals Group Co is Fairly Valued.

Jacobio Pharmaceuticals Group Co (HKSE:01167) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Jacobio Pharmaceuticals Group Co's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	1.78	/	1.78
	=	1.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jacobio Pharmaceuticals Group Co GF Value Related Terms

Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Jacobio Pharmaceuticals Group Co (HKSE:01167) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

JBPHF:USA

Address

No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN

Website

http://www.jacobiopharma.com

Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.

Executives

Shen Zhu	2501 Other
Treasure Partner International Limited	2501 Other
Ultimate Estate Limited	2201 Interest of corporation controlled by you
Wang Yinxiang	2501 Other
Wang Xiaojie	2307 Founder of a discretionary trust who can infl
Hu Yunyan	2501 Other
Yakovpharma Ltd	2501 Other
Willgenpharma Ltd	2501 Other
Risepharma Ltd	2101 Beneficial owner
Johwpharma Ltd	2501 Other
Hmed Ltd	2501 Other
Gloryviewpharma Ltd	2501 Other
Honourpharma Ltd	2501 Other
Blesspharma Ltd	2501 Other
Hillhouse Investment Management, Ltd.	2102 Investment manager

Jacobio Pharmaceuticals Group Co (HKSE:01167) Headlines

No Headlines